AVITA Medical RCEL
NASDAQ RCEL
$17.30 -0.35 (-1.98%)
At close: Nov 11, 2026 · 4:00 PM EST

AVITA Medical (RCEL) Amortization of Deferred Charges (2021 - 2023)

Updated

AVITA Medical (RCEL) posted Amortization of Deferred Charges of $86,000 for Q4 2023, up 1.2% from $85,000 a year earlier and up 1.2% from the prior quarter.

Analysis

AVITA Medical (RCEL) Amortization of Deferred Charges (2021 - 2023) Analysis & Trends

For FY2023, AVITA Medical's Amortization of Deferred Charges came in at $341,000, up 0.9% from FY2022.

  • In prior years, AVITA Medical's Amortization of Deferred Charges was $338,000 in FY2022 (+102.4%) and $167,000 in FY2021.
  • According to Business Quant data, Amortization of Deferred Charges for the three prior quarters was $85,000 (Q3 2023), $85,000 (Q2 2023) and $85,000 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 AVITA Medical 546.49 Mn 492.41 Mn 21.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 86,000.00
Sep 30, 2023 85,000.00
Jun 30, 2023 85,000.00
Mar 31, 2023 85,000.00
Dec 31, 2022 86,000.00
Mar 31, 2022 85,000.00
Sep 30, 2021 82,000.00
Mar 31, 2021 50,000.00
API Access

AVITA Medical Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=RCEL&period=max&api_key=YOUR_API_KEY